AstraZeneca Pauses £200 Million Expansion in Cambridge
London: British drug giant AstraZeneca has paused a planned £200 million expansion of its research site in Cambridge, the company said. This decision follows the pharmaceutical firm’s abandonment of plans to invest £450 million in a vaccine plant in M…